Cadence Pharmaceuticals Inc.
) was a big mover last session, as the company saw its shares rise
by 34% on the day. The move came on solid volume too with far more
shares changing hands than in a normal session. This continues the
recent uptrend for the company, as the stock is now up over 36% in
the past one-month time frame.
This biopharmaceutical stock has seen two positive estimate
revisions in the past one month and its Zacks Consensus Estimate
has also moved higher over the same time frame, suggesting that
more solid trading ahead. So make sure to keep an eye on this
stock, going forward, to see if the current rally can turn into
more strength down the road.
Cadence currently has a Zacks Rank #3 (Hold) and its
However, some better performing stocks in the same industry are
BioSpecifics Technologies Corp.
Furiex Pharmaceuticals, Inc.
Jazz Pharmaceuticals Public Limited Company
). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
BIOSPECIFICS TE (BSTC): Get Free Report
CADENCE PHARMA (CADX): Free Stock Analysis
FURIEX PHARMACT (FURX): Free Stock Analysis
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis
To read this article on Zacks.com click here.